Monday was quite the day for biotech companies developing the next generation of obesity drugs. One of them, Structure ...

A recent Bloomberg Intelligence study found that buyside European equity traders want lighter regulation, more retail flow ...

Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

Binance, the world's largest crypto exchange, has reportedly secured three crucial financial licenses in Abu Dhabi's Global ...

Binance secures full FSRA approval, adopting a 3-entity ADGM model that sets new global crypto compliance standards.

US stocks fell on Monday as Wall Street awaited the Federal Reserve's final policy meeting of the year, while the deal drama ...

Gold Royalty has transitioned to recurring cash flow, with two consecutive quarters of positive operational cash flow and ...

Investing.com -- Structure Therapeutics Inc. (NASDAQ:GPCR) stock fell 4.1% in after-hours trading Monday following the announcement of a proposed $500 million public offering, giving back some of its ...

Kolkata's historic New Market, known as SS Hogg Market, is set to receive significant structural reinforcements to enhance ...

US stocks fell on Monday as Wall Street headed into a pivotal week dominated by the Federal Reserve's final policy meeting of ...

Among the various execution tools European traders use, Systematic Internalizers and Periodic Auctions play a key role in ...

Robust XRP-spot ETF demand, expanding global access, and crypto-friendly regulation drive a bullish medium-term path, with $2 ...